Literature DB >> 28346809

MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p.

Ke Liu1, Jun Huang2, Jiangdong Ni2, Deye Song2, Muliang Ding2, Junjie Wang2, Xianzhe Huang2, Wenzhao Li2.   

Abstract

Recently, emerging evidence has demonstrated that metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), a long non-coding RNAs (lncRNAs), contributes to the initiation and development of tumors, including osteosarcoma (OS). Multiple studies have suggested an oncogenic role of MALAT1 and high-mobility group protein B1 (HMGB1) in OS tumorigenesis and metastasis, but the effects and mechanisms are not unanimous. Here, we showed that MALAT1 and HMGB1 were significantly increased in human OS cell lines and knockdown of MALAT1 reduced HMGB1 expression. By using online tools, we screen out 2 candidate miRNAs, miR-142-3p and miR-129-5p which may be associated with both MALAT1 and HMGB1. Luciferase reporter assay revealed a direct interaction between the 2 miRNAs and MALAT1, respectively, via a putative binding site within MALAT1. Meanwhile, both the 2 miRNAs could bind to HMGB1 3'-untranslated region (3'-UTR) and regulate HMGB1 expression. Moreover, knockdown of MALAT1 decreased HMGB1 expression, inhibited OS cell growth and promoted apoptosis, while miR-142-3p and miR-129-5p inhibitor partly restored the inhibitory effect of MALAT1 knockdown on HMGB1 expression, OS cell growth and the promotion of apoptosis. In OS tissues, the expression of MALAT1 and HMGB1 was upregulated while the expression of miR-142-3p and miR-129-5p was downregulated. Together, our results support a MALAT1/miR-142-3p/miR-129-5p/HMGB1 axis in OS cell proliferation and tumor progression. MALAT1 promoted OS cell growth through inhibition of miR-142-3p or miR-129-5p and by targeting HMGB1.

Entities:  

Keywords:  HMGB1; lncRNA-MALAT1; miR-129–5p; miR-142–3p; osteosarcoma

Mesh:

Substances:

Year:  2017        PMID: 28346809      PMCID: PMC5384591          DOI: 10.1080/15384101.2017.1288324

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  37 in total

1.  Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma.

Authors:  Jun Huang; Ke Liu; Yan Yu; Min Xie; Rui Kang; Philip Vernon; Lizhi Cao; Daolin Tang; Jiangdong Ni
Journal:  Autophagy       Date:  2012-02-01       Impact factor: 16.016

2.  MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.

Authors:  Yongqiang Dong; Guojun Liang; Bo Yuan; Chaoqun Yang; Rui Gao; Xuhui Zhou
Journal:  Tumour Biol       Date:  2014-11-28

3.  Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.

Authors:  Hiroshi Hirata; Yuji Hinoda; Varahram Shahryari; Guoren Deng; Koichi Nakajima; Z Laura Tabatabai; Nobuhisa Ishii; Rajvir Dahiya
Journal:  Cancer Res       Date:  2015-01-19       Impact factor: 12.701

4.  MiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancer.

Authors:  Zhe Lei; Guili Xu; Longqiang Wang; Haiping Yang; Xia Liu; Jun Zhao; Hong-Tao Zhang
Journal:  FASEB J       Date:  2014-02-20       Impact factor: 5.191

5.  MiR-205 functions as a tumor suppressor via targeting TGF-α in osteosarcoma.

Authors:  Guojin Yang; Peng Zhang; Aibin Lv; Yulin Liu; Guoxi Wang
Journal:  Exp Mol Pathol       Date:  2015-12-17       Impact factor: 3.362

Review 6.  A pathophysiological view of the long non-coding RNA world.

Authors:  Federico Di Gesualdo; Sergio Capaccioli; Matteo Lulli
Journal:  Oncotarget       Date:  2014-11-30

7.  miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110.

Authors:  Irene V Bijnsdorp; Jasmina Hodzic; Tonny Lagerweij; Bart Westerman; Oscar Krijgsman; Jurjen Broeke; Frederik Verweij; R Jonas A Nilsson; Lawrence Rozendaal; Victor W van Beusechem; Jeroen A van Moorselaar; Thomas Wurdinger; Albert A Geldof
Journal:  Oncotarget       Date:  2016-03-29

8.  microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements.

Authors:  Alexander Schwickert; Esther Weghake; Kathrin Brüggemann; Annika Engbers; Benjamin F Brinkmann; Björn Kemper; Jochen Seggewiß; Christian Stock; Klaus Ebnet; Ludwig Kiesel; Christoph Riethmüller; Martin Götte
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

9.  The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression.

Authors:  Andrew E Tee; Bing Liu; Renhua Song; Jinyan Li; Eddy Pasquier; Belamy B Cheung; Cizhong Jiang; Glenn M Marshall; Michelle Haber; Murray D Norris; Jamie I Fletcher; Marcel E Dinger; Tao Liu
Journal:  Oncotarget       Date:  2016-02-23

10.  Long non-coding RNA TUSC7 acts a molecular sponge for miR-10a and suppresses EMT in hepatocellular carcinoma.

Authors:  Yufeng Wang; Zhikui Liu; Bowen Yao; Changwei Dou; Meng Xu; Yumo Xue; Linglong Ding; Yuli Jia; Hongyong Zhang; Qing Li; Kangsheng Tu; Yang Jiao; Qingguang Liu; Cheng Guo
Journal:  Tumour Biol       Date:  2016-03-22
View more
  59 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

Review 2.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

3.  The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis.

Authors:  You Zhou; Ling Yin; Hui Li; Li-Hong Liu; Tao Xiao
Journal:  Cancer Biol Ther       Date:  2019-04-12       Impact factor: 4.742

4.  LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.

Authors:  Yanbei Sun; Tingxiu Jiang; Yongqing Jia; Jingyun Zou; Xiaoxiao Wang; Weiying Gu
Journal:  Cell Cycle       Date:  2019-08-09       Impact factor: 4.534

5.  Long noncoding RNA LeXis promotes osteosarcoma growth through upregulation of CTNNB1 expression.

Authors:  Guijiang Wang; Tao Cui; Lishan Sun; Ningning Peng; Cheng Yang
Journal:  Am J Cancer Res       Date:  2017-07-01       Impact factor: 6.166

6.  The effect of dexmedetomidine on biological behavior of osteosarcoma cells through miR-1307 expression.

Authors:  Yanping Liu; Xiaopeng Gu; Yongtao Liu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

7.  MicroRNA-142-3p inhibits proliferation and induces apoptosis by targeting the high-mobility group box 1 via the Wnt/β-catenin signaling pathway in glioma.

Authors:  Chong Li; Shiyu Feng; Ling Chen
Journal:  Int J Clin Exp Pathol       Date:  2018-09-01

8.  Long non-coding RNA NONHSAT101069 promotes epirubicin resistance, migration, and invasion of breast cancer cells through NONHSAT101069/miR-129-5p/Twist1 axis.

Authors:  Na Yao; Yue Fu; Lie Chen; Zhao Liu; Jing He; Yichao Zhu; Tiansong Xia; Shui Wang
Journal:  Oncogene       Date:  2019-08-23       Impact factor: 9.867

9.  Mechanism of Cyclic Tensile Stress in Osteogenic Differentiation of Human Periodontal Ligament Stem Cells.

Authors:  Xiayi Wu; Yi Li; Zeyuan Cao; Yunyi Xie; Chuanqiang Fu; Huan Chen
Journal:  Calcif Tissue Int       Date:  2021-01-12       Impact factor: 4.333

Review 10.  HMGB1 as a therapeutic target in disease.

Authors:  Jiaming Xue; Joelle S Suarez; Michael Minaai; Shuangjing Li; Giovanni Gaudino; Harvey I Pass; Michele Carbone; Haining Yang
Journal:  J Cell Physiol       Date:  2020-10-26       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.